Philipp Schachtschneider

Suggest Changes
Learn More
The insulin-like growth factor-I receptor (IGF-IR) is frequently overexpressed and constitutively activated in pancreatic cancer, thus representing a promising target for therapy. We investigated the(More)
  • 1